Stay updated on BBI503 Combo with Anti-Cancer Agents Clinical Trial

Sign up to get notified when there's something new on the BBI503 Combo with Anti-Cancer Agents Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BBI503 Combo with Anti-Cancer Agents Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; Back to Top element removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:42:21.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information and related topics, while several previous terms and categories have been removed, including some specific drug classifications and location details.
    Difference
    6%
    Check dated 2025-09-06T15:28:07.000Z thumbnail image
  3. Check
    24 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:50:02.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T00:15:14.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-01T19:35:41.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.16.6 to v2.16.8 and added a section on HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-07-25T15:12:22.000Z thumbnail image

Stay in the know with updates to BBI503 Combo with Anti-Cancer Agents Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BBI503 Combo with Anti-Cancer Agents Clinical Trial page.